v3 Template
M
Molecular Templates
Biopharmaceutical
Founded
--
Employees
--
Total Funding
$49.5M
Funding Rounds
2
Last Funding
2024-03-28
About Molecular Templates
Molecular Templates, Inc. is a clinical-stage biopharmaceutical company that was formerly based in Austin, TX. The company is no longer operating.
Funding History
Debug: View Raw Funding Data
| # | Type | Amount Fields | Date Fields | Investors |
|---|---|---|---|---|
| 1 |
RT: Private Placement T: - FT: Private Placement |
A: 9500000 MR: - FA: $9.5 million FAN: 9500000 |
D: 2024-03-28 FD: 2024-03-28 |
4 investors |
| 2 |
RT: Private Placement T: - FT: Private Placement |
A: 40000000 MR: - FA: up to $40 million FAN: 40000000 |
D: 2023-07-13 FD: 2023-07-13 |
4 investors |
Private Placement
Latest
2024-03-28
$9.5M
4 investors (Pro only)
Private Placement
2023-07-13
$40.0M
Growth Metrics
+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active
Mock Up
Team & Leadership
No team data available
Team information is not yet available for this company
Recent News
Molecular Templates Announces New Product Launch
2 days agoCompany unveils innovative solution to transform the industry, expanding market reach and capabilities...
Read more →Leadership Team Expands with Industry Veteran
1 week agoNew executive brings 20+ years of experience to accelerate growth and strategic initiatives...
Read more →Company Recognized as Industry Leader
2 weeks agoReceives prestigious award for innovation and customer satisfaction in competitive market...
Read more →Mock Up
Key Competitors
C1
Competitor Alpha
Series B · $50M raised
C2
Competitor Beta
Series C · $120M raised
C3
Competitor Gamma
Series A · $25M raised
C4
Competitor Delta
Seed · $10M raised
Mock Up
Company Details
- Website
- mtem.com
- Industries
- Biopharmaceutical
Similar Companies
Discover AI-powered company recommendations based on industry, funding, and team profiles.
Upgrade to ProTechnology Stack
Discover the backend, frontend, and infrastructure technologies powering this company's products.
Upgrade to Pro